About Index Trending news
Lists
Pricing
SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$38,000,000
Venture capital (Series B)
$20,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Caveats But No "Quicksand" In Sage's Positive Postpartum Trial Data

Health
The Motley Fool

Here's Why Sage Therapeutics' Stock Is Falling Today

Health Stock markets